These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12165272)

  • 21. Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort.
    McCarthy EM; Lee RZ; Ní Gabhann J; Smith S; Cunnane G; Doran MF; Howard D; O'Connell P; Kearns G; Jefferies CA
    Rheumatology (Oxford); 2013 Jul; 52(7):1279-84. PubMed ID: 23479724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients.
    Süsal C; Oberg HH; Daniel V; Dörr C; Terness P; Huth-Kühne A; Zimmermann R; Opelz G
    Vox Sang; 1994; 66(1):37-45. PubMed ID: 7908473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+ lymphocyte decrease in HIV disease: association with anti-CD4+ but not with anti-CD8+ lymphocyte autoantibodies.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Gerhard I; Maier H; Opelz G
    Vox Sang; 1996; 70(2):86-91. PubMed ID: 8801768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
    Müller C; Kukel S; Bauer R
    Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BLyS levels in sera of patients with systemic lupus erythematosus: clinical and serological correlation.
    Elbirt D; Asher I; Mahlab-Guri K; Bezalel-Rosenberg S; Edelstein V; Sthoeger Z
    Isr Med Assoc J; 2014 Aug; 16(8):491-6. PubMed ID: 25269340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.
    Collins CE; Gavin AL; Migone TS; Hilbert DM; Nemazee D; Stohl W
    Arthritis Res Ther; 2006; 8(1):R6. PubMed ID: 16356193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.
    Novak AJ; Grote DM; Ziesmer SC; Kline MP; Manske MK; Slager S; Witzig TE; Shanafelt T; Call TG; Kay NE; Jelinek DF; Cerhan JR; Gross JA; Harder B; Dillon SR; Ansell SM
    J Clin Oncol; 2006 Feb; 24(6):983-7. PubMed ID: 16432079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans.
    Fontaine J; Chagnon-Choquet J; Valcke HS; Poudrier J; Roger M;
    Blood; 2011 Jan; 117(1):145-55. PubMed ID: 20870901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of viral load in plasma samples of HIV-infected hemophilia patients with autoantibodies and gp120-containing immune complexes on CD4+ lymphocytes.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Melk A; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 1998 Feb; 60(2-3):179-87. PubMed ID: 9557961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of autoantibodies in HIV infection.
    Massabki PS; Accetturi C; Nishie IA; da Silva NP; Sato EI; Andrade LE
    AIDS; 1997 Dec; 11(15):1845-50. PubMed ID: 9412703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals.
    Dieye TN; Sow PS; Simonart T; Guèye-Ndiaye A; Popper SJ; Delforge ML; Dieye A; Sarr AD; Crusiaux A; Van Vooren JP; Devleeschouwer M; Kanki P; Mboup S; Diakhate L; Farber CM
    Vaccine; 2001 Dec; 20(5-6):905-13. PubMed ID: 11738756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus.
    Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Roschke V; Wu Y; Baker KP; Hilbert DM
    Ann Rheum Dis; 2004 Sep; 63(9):1096-103. PubMed ID: 15308519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV Nef promotes expression of B-lymphocyte stimulator by blood dendritic cells during HIV infection in humans.
    Chagnon-Choquet J; Gauvin J; Roger J; Fontaine J; Poudrier J; Roger M;
    J Infect Dis; 2015 Apr; 211(8):1229-40. PubMed ID: 25378636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro.
    Pellegrino MG; Bluth MH; Smith-Norowitz T; Fikrig S; Volsky DJ; Moallem H; Auci DL; Nowakowski M; Durkin HG
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):363-72. PubMed ID: 11897038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
    Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
    Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface immunoglobulin-positive T lymphocytes in HIV-1 infection: relationship to CD4+ lymphocyte depletion.
    Ardman B; Mayer K; Bristol J; Ryan M; Settles M; Levy E
    Clin Immunol Immunopathol; 1990 Aug; 56(2):249-58. PubMed ID: 1974180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.